MAINOLFI NELLO (President and CEO) sold 10.7% of their position (80K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.22M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+80K
Price / share
$2.08
Trade value
$166.40K
% of position
Common Stock
Shares
−1.88K
Price / share
$112.80
Trade value
$212.41K
% of position
Common Stock
Shares
−6.63K
Price / share
$113.98
Trade value
$755.20K
% of position
Common Stock
Shares
−24.11K
Price / share
$114.96
Trade value
$2.77M
% of position
Common Stock
Shares
−44.05K
Price / share
$115.69
Trade value
$5.10M
% of position
Common Stock
Shares
−3.34K
Price / share
$116.56
Trade value
$388.84K
% of position
Net shares
+0.00
Net value
-$9.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +80K | $2.08 | $166.40K | 12.0% | 666.57K | 746.57K |
| Common Stock Direct | 7/1/2026 | S · Sale | −1.88K | $112.80 | $212.41K | 0.3% | 746.57K | 744.68K |
| Common Stock Direct | 7/1/2026 | S · Sale | −6.63K | $113.98 | $755.20K | 0.9% | 744.68K | 738.06K |
| Common Stock Direct | 7/1/2026 | S · Sale | −24.11K | $114.96 | $2.77M | 3.3% | 738.06K | 713.95K |
| Common Stock Direct | 7/1/2026 | S · Sale | −44.05K | $115.69 | $5.10M | 6.2% | 713.95K | 669.90K |
| Common Stock Direct | 7/1/2026 | S · Sale | −3.34K | $116.56 | $388.84K | 0.5% | 669.90K | 666.57K |
| Total | +0.00 | -$9.06M | ||||||
Stock Option (Right to Buy)
Common Stock
80K shares
Shares
−80K
Strike price
2.08
Held after
135.56K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock80K shares | 7/1/2026 | M · Option Exercise | −80K | 2.08 | — | 135.56K |